Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Raps Supplement Maker Marco Pharma For GMP Violations Surfaced During Inspection

Feb 05 2020

• By Eileen Francis

WarningSign_1200x675

Related Content

FDA Warning Letter To Balance of Nature Cites Disease Claims On Supplements, GMP Violations

Feb 05 2020

Supplement GMP Documentation Better, But Still No. 2 On FDA Observation List – AHPA

Dec 23 2019

Additional Topics

United States FDA Enforcement Dietary Supplements Regulation Consumer

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window